From Prototype to Profit: Commercialization Insights

OTI Lumionics' new method on a single GPU simulates complex molecules in one hour, a task that could take a future quantum computer up to 200 hours.

Two best friends trade corporate careers for a new Blo Blow Dry Bar, championing employee healthcare, community partnership, and female empowerment.

After a six-month stalemate, 750 striking nurses are taking their fight with Henry Ford Genesys to Lansing, drawing in top political figures.

Amid a tough property market, Beike's $300M dividend and massive buybacks highlight its financial strength and a commitment to rewarding investors.

A data breach at employee benefits firm DHCA exposed the personal data of over 36,600 people. The firm's nearly 3-month delay in notifying victims is now raising alarms.

China's Lianhe Sowell joins forces with World Mobile and OOKC in an ambitious plan to build a decentralized, AI-powered global communications network.

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

Verily Me's AI 'Violet' promises personalized health advice, but a looming lawsuit raises serious questions about data privacy and user trust.

An award-winning AI is revolutionizing chiropractic offices by automating notes and compliance, allowing doctors to focus solely on their patients.

Semiconductor leader Melexis launches an autonomous China entity, aiming to dominate the EV and robotics markets by operating at local market velocity.

Psyence BioMed is building a pharmaceutical powerhouse by controlling its supply chain, a strategic move that could redefine the future of psychedelic medicine.

A new partnership aims to bring institutional-grade defined outcome strategies to the masses, blending ETFs and structured notes to deliver buffered protection.

After building a US powerhouse, Merri Jo Cowen now leads UCO to bring MLS transparency to global markets as a new CEO takes the helm at home.

Following a major investment, Trialbee appoints a seasoned leader to its board, signaling a push for dominance in AI-driven clinical trial recruitment.

A new initiative aims to help local shops and restaurants capitalize on the billion-dollar economic impact of the 2026 global soccer championship in Dallas.

With a network reaching 1.2M providers, ConnectiveRx is embedding pharma messaging into clinical workflows. Is it the future of patient care or a new frontier of commercial influence?

Services-focused PE firm Uplift Investors hires Evan Trent to lead a new M&A and Integration Center, signaling a deep focus on post-deal execution.

A groundbreaking analysis quantifies the hidden costs of common IV failures, showing how early detection technology can save lives and boost hospital margins.

OSE Immunotherapeutics confirms Marc Le Bozec as CEO, betting on his turnaround expertise to navigate market pressures and commercialize its key therapies.

Backed by trading firm Susquehanna, UK prediction market Smarkets files for a U.S. license, aiming to challenge sportsbooks with its exchange model.